지난 50년간 국내 항생제 내성의 변화와 향후 전망 - 그람음성 세균

키워드

참고문헌 (92)

1. Brötz-Oesterhelt H, "Postgenomic strategies in antibacterial drug discovery", Future Microbiol, 5, pp.1553~1579 (2010)
2. 이경원, "Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens", Yonsei Medical Journal, 52(6), pp.879~891 (2011), 연세대학교의과대학
3. Song JH, "Spread of methicillinresistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study", J Antimicrob Chemother, 66, pp.1061~1069 (2011)
4. Chong Y, "Quality control of antibiotic susceptibility testing", J Korean Med Assoc, 20, pp.433~440 (1977)
5. Performance standards for antimicrobial disk susceptibility tests-proposed standard, "National Committee for Clinical Laboratory Standards", NCCLS, ~ (1975)
6. Park SH, "Pathogenic bacteria isolated from Korean patients", Korean J Infect Dis, 1, pp.33~48 (1969)
7. Park SH, "Antibiotic susceptibility of pathogenic microorganisms isolated in 1969", J Korean Med Assoc, 13, pp.71~80 (1970)
8. Park SJ, "Antibiotic susceptibility of clinical isolates of bacteria", Korean J Pathol, 11, pp.119~125 (1977)
9. Chung HY, "The changing pattern of antimicrobial susceptibility of hospital isolates", Korean J Infect Dis, 18, pp.1~10 (1986)
10. Chong Y, "Trend of antimicrobial agent resistance of bacteria isolated from clinical materials", Korean J Infect Dis, 21, pp.243~255 (1989)
11. Lee K, "Antimicrobial susceptibilities of bacteria isolated during 1988-1992", J Korean Soc Chemother, pp.158~168 (1993)
12. Shah PM, "Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporins", J Antimicrob Chemother, 11, pp.598~598 (1983)
13. Bradford PA, "Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat", Clin Microbiol Rev, 14, pp.933~951 (2001)
14. Paterson DL, "Extended-spectrum β-lactamases: a clinical update", Clin Microbiol Rev, 18, pp.657~686 (2005)
15. Bonnet R, "Growing group of extended-spectrum β-lactamases: the CTX-M enzymes", Antimicrob Agents Chemother, 48, pp.1~14 (2004)
16. Lee K, "Prevalence of extended broad-spectrum β-lactamase in Escherichia coli and Klebsiella pneumoniae", Korean J Infect Dis, 26, pp.341~348 (1994)
17. Chong Y, "Korean nationwide surveillance of antimicrobial resistance of bacteria in 1997", Yonsei Med J, 39, pp.569~577 (1998)
18. Kyungwon Lee, "Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009", Yonsei Medical Journal, 52(5), pp.793~802 (2011), 연세대학교의과대학
19. Chong Y, "Characteristics of extended- spectrum β-lactam hydrolyzing activity of Klebsiella pneumoniae and Escherichia coli strains isolated from clinical specimens", Korean J Infect Dis, 29, pp.477~485 (1997)
20. Pai H, "Characterization of extended spectrum β-lactamase in Klebsiella pneumoniae isolated in Korea", Korean J Infect Dis, 29, pp.93~103 (1997)
21. Kim J, "Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea", J Clin Microbiol, 36, pp.1446~1449 (1998)
22. Pai H, "Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea", J Clin Microbiol, 37, pp.1758~1763 (1999)
23. Lee K, "Diversity of TEM- 52 extended-spectrum β-lactamase-producing non-typhoidal Salmonella isolates in Korea", J Antimicrob Chemother, 52, pp.493~496 (2003)
24. Pai H, "Identification of CTX-M-14 extended-spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea", J Clin Microbiol, 39, pp.3747~3749 (2001)
25. Jeong SH, "Investigation of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea", LETTERS IN APPLIED MICROBIOLOGY, 39(1), pp.41~47 (2004)
26. Pai H, "A nosocomial outbreak of Escherichia coli producing CTX-M-15 and OXA-30 β-lactamase", Infect Control Hosp Epidemiol, 27, pp.312~314 (2006)
27. Park YJ, "Occurrence of extended-spectrum β-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 51(4), pp.265~269 (2005)
28. Park YJ, "Occurrence of extended-spectrum β-lactamases and plasmid-mediated AmpC β-lactamases among Korean isolates of Proteus mirabilis", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 57(1), pp.156~158 (2006), OXFORD UNIV PRESS
29. Song W, "CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum β-lactamase in clinical isolates of Escherichia coli from Korea", Journal Of Medical Microbiology, 58(2), pp.261~266 (2009)
30. Song W, "Chromosome-Encoded AmpC and CTX-M Extended-Spectrum beta-Lactamases in Clinical Isolates of Proteus mirabilis from Korea", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 55(4), pp.1414~1419 (2011), AMER SOC MICROBIOLOGY
31. Lee K, "Evolution of resistance and spread of multidrug-resistant bacteria" (2007), Seo Heung Publishing co
32. Pai H, "High prevalence of extended-spectrum β-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns", Antimicrob Agents Chemother, 48, pp.3159~3161 (2004)
33. Kim J, "Prevalence of derepressed ampC mutants and extended-spectrum β-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12", J Clin Microbiol, 43, pp.2452~2455 (2005)
34. Bauernfeind A, "Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins", Infection, 17, pp.316~321 (1989)
35. Papanicolaou GA, "Novel plasmidmediated β-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae", Antimicrob Agents Chemother, 34, pp.2200~2209 (1990)
36. Fosberry AP, "Cloning and sequence analysis of blaBIL-1, a plasmid-mediated class C β-lactamase gene in Escherichia coli BS", Antimicrob Agents Chemother, 38, pp.1182~1185 (1994)
37. Gonzalez Leiza M, "Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated β-lactamase with two molecular variants", Antimicrob Agents Chemother, 38, pp.2150~2157 (1994)
38. Horii T, "Characterization of a plasmid-borne and constitutively expressed blaMOX-1 gene encoding AmpC-type β-lactamase", Gene, 139, pp.93~98 (1994)
39. Barnaud G, "Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii", Antimicrob Agents Chemother, 42, pp.2352~2358 (1998)
40. Tzouvelekis LS, "Identification of a novel plasmid-mediated β-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae", J Antimicrob Chemother, 31, pp.645~654 (1993)
41. Bradford PA, "Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the foss of an outer membrane protein", Antimicrob Agents Chemother, 41, pp.563~569 (1997)
42. Bauernfeind A, "A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia", Antimicrob Agents Chemother, 43, pp.1924~1931 (1999)
43. Lee K, "Prevalence of plasmid-mediated AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea", MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 12(1), pp.44~49 (2006)
44. Yoo JS, "High prevalence of extended-spectrum β-lactamases and plasmidmediated AmpC β-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea", Diagn Microbiol Infect Dis, 67, pp.261~265 (2010)
45. Papp-Wallace KM, "Carbapenems: past, present, and future", Antimicrob Agents Chemother, 55, pp.4943~4960 (2011)
46. Lee K, "Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 β-lactamases co-mediated by porin loss", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 29, pp.201~206 (2007)
47. Queenan AM, "Carbapenemases: the versatile β- lactamases", Clin Microbiol Rev, 20, pp.440~458 (2007)
48. Yigit H, "Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem- resistant strain of Klebsiella pneumoniae", Antimicrob Agents Chemother, 45, pp.1151~1161 (2001)
49. Watanabe M, "Transferable imipenem resistance in Pseudomonas aeruginosa", Antimicrob Agents Chemother, 35, pp.147~151 (1991)
50. Donald HM, "Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92", Antimicrob Agents Chemother, 44, pp.196~199 (2000)
51. Walther-Rasmussen J, "OXA-type carbapenemases", J Antimicrob Chemother, 57, pp.373~383 (2006)
52. Walsh TR, "Metallo-β- lactamases: the quiet before the storm", Clin Microbiol Rev, 18, pp.306~325 (2005)
53. Lee K, "Novel acquired metallo-β-lactamase gene, blaSIM-1, n a class integron from Acinetobacter baumannii clinical isolates from Korea", Antimicrob Agents Chemother, 49, pp.4485~4491 (2005)
54. Gupta V, "Metallo β-lactamases in Pseudomonas aeruginosa and Acinetobacter species", Expert Opin Investig Drugs, 17, pp.131~143 (2008)
55. Poirel L, "Characterization of DIM-1, an integron-encoded metallo-β-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands", Antimicrob Agents Chemother, 54, pp.2420~2424 (2010)
56. Yong D, "Characterization of a New Metallo-beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India", Antimicrobial Agents And Chemotherapy, 53(12), pp.5046~5054 (2009)
57. Sekiguchi J, "KHM-1, a novel plasmid-mediated metallo-β-lactamase from a Citrobacter freundii clinical isolate", Antimicrob Agents Chemother, 52, pp.4194~4197 (2008)
58. Lee K, "blaVIM-2 cassettes-containing novel integrons in metallo- β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital", Antimicrob Agents Chemother, 46, pp.1053~1058 (2002)
59. Yum JH, "Molecular characterization of metallo-β-lactamaseproducing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two novel integrons carrying blaVIM-2 gene cassettes", J Antimicrob Chemother, 49, pp.837~840 (2002)
60. Yum JH, "A new integron carrying VIM-2 metallo-β-lactamase gene cassette in a Serratia marcescens isolate", Diagn Microbiol Infect Dis, 42, pp.217~219 (2002)
61. "Characterization of a new integron containing VIM-2, a metallo-beta-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 51, pp.397~400
62. Lee K, "VIMand IMP-type metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals", Emerg Infect Dis, 9, pp.868~871 (2003)
63. Ryoo NH, "Outbreak by meropenem-resistant Pseudomonas aeruginosa producing IMP-6 metallo-beta-lactamase in a Korean hospital", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 63, pp.115~115~117 (2009)
64. Lee K, "Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-beta-lactamases", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 36, pp.259~263 (2010), ELSEVIER
65. Kim MN, "Characterization of NDM-1-producing Klebsiella pneumoniae isolated from four Korean patients within a month", 51th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (2011)
66. Bradford PA, "Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City", Clin Infect Dis, 39, pp.55~60 (2004)
67. Hossain A, "Plasmidmediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp", Antimicrob Agents Chemother, 48, pp.4438~4440 (2004)
68. Villegas MV, "First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America", Antimicrob Agents Chemother, 50, pp.2880~2882 (2006)
69. Naas T, "Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumonia isolate from France", Antimicrob Agents Chemother, 49, pp.4423~4424 (2005)
70. Rhee JY, "KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea", Antimicrob Agents Chemother, 54, pp.2278~2279 (2010)
71. 노경호, "Isolation of a Klebsiella pneumoniae Isolate of Sequence Type 258 Producing KPC-2 Carbapenemase in Korea", Annals of Laboratory Medicine, 31(4), pp.298~301 (2011), 대한진단검사의학회
72. Yoo J, "Emergence of KPC-2 producing Klebsiella pneumoniae ST258 isolates from national surveillance for carbapenem-resistant Enterobacteriaceae (CRE) in Korea", 51th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (2011)
73. Afzal-Shah M, "Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii", Antimicrob Agents Chemother, 45, pp.583~588 (2001)
74. Naas T, "Pyrosequencing for rapid identification of carbapenem-hydrolyzing OXA-type β-lactamases in Acinetobacter baumannii", Clin Microbiol Infect, 12, pp.1236~1240 (2006)
75. Lee Y, "Carbapenem-nonsusceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene", J Antimicrob Chemother, 66, pp.66~72 (2011)
76. Lee K, "Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea", International Journal Of Antimicrobial Agents, 33(6), pp.520~524 (2009)
77. Livermore DM, "Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London", Int J Antimicrob Agents, 35, pp.19~24 (2010)
78. Ko KS, "High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 60(5), pp.1163~1167 (2007), OXFORD UNIV PRESS
79. 송원근, "국내의 Acinetobacter baumannii와 Pseudomonas aeruginosa 임상분리주에 대한 Colistin과 Polymyxin B의 감수성 양상", Infection and Chemotherapy, 38(6), pp.362~366 (2006), 대한감염학회
80. Kim CK, "Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182", Diagnostic Microbiology And Infectious Disease, 68(4), pp.432~438 (2010), Elsevier BV
81. Galimand M, "Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation", Antimicrob Agents Che mother, 47, pp.2565~2571 (2003)
82. Lee H, "Dissemination of 16S rRNA methylase-mediated highly amikacin-resistant isolates of Klebsiella pneumoniae and Acinetobacter baumannii in Korea", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 56, pp.305~312 (2006)
83. "JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY", 2006, 907~908, pp.OXFORD UNIV PRESS
84. Lai CC, "Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare- associated infections at a university hospital in Taiwan from 2000 to 2009", J Antimicrob Chemother, 66, pp.1374~1382 (2011)
85. Kim SI, "Trend of antimicrobial usage in Korea", 2011 KFDA International Symposium on Antimicrobial Resistance (2011)
86. Hooper DC, "Emerging mechanisms of fluoroquinolone resistance", Emerg Infect Dis, 7, pp.337~341 (2001)
87. Robicsek A, "The worldwide emergence of plasmid-mediated quinolone resistance", Lancet Infect Dis, 6, pp.629~640 (2006)
88. Jeong JY, "Detection of qnr in clinical isolates of Escherichia coli from Korea", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 49(6), pp.2522~2524 (2005), AMER SOC MICROBIOLOGY
89. Pai H, "Association of QnrB determinants and production of extended-spectrum β-lactamases or plasmid-mediated AmpC β-lactamases in clinical isolates of Klebsiella pneumoniae", Antimicrob Agents Chemother, 51, pp.366~368 (2007)
90. Park YJ, "Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multi-centre study from Korea", J Antimicrob Chemother, 60, pp.868~871 (2007)
91. 정행순, "Prevalence of Plasmid-mediated Quinolone Resistance and Its Association with Extended-spectrum Beta-lactamase and AmpC Beta-lactamase in Enterobacteriaceae", Annals of Laboratory Medicine, 31(4), pp.257~264 (2011), 대한진단검사의학회
92. Kallen AJ, "Current epidemiology of multidrugresistant gram-negative bacilli in the United States", Infect Control Hosp Epidemiol, 31(1), pp.S51~S54 (2010)

관련 논문AI추천